NEW YORK, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: SCPS) (“Scopus” or the “Company”) today announced that it has filed an amendment to the Current Report on Form 8-K that was ...
NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet ...
We are delighted to announce that npj Ocean Sustainability has achieved a significant milestone by being accepted for inclusion in Scopus by the Scopus Content Selection & Advisory Board (CSAB) on 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback